GSK

GLAXOSMITHKLINE PLC ORD 25P

TitleTime
Holding(s) in CompanyTue 19/05/20 | 17:51
ViiV PrEP jab shows high efficacy over daily pillMon 18/05/20 | 07:09
Director/PDMR ShareholdingWed 13/05/20 | 17:04
Director/PDMR ShareholdingMon 11/05/20 | 18:07
Publication of Final TermsThu 07/05/20 | 17:43
Director/PDMR ShareholdingThu 07/05/20 | 15:52
GSK sells its holding in Hindustan UnileverThu 07/05/20 | 07:56
Result of AGMWed 06/05/20 | 17:40
Director/PDMR ShareholdingMon 04/05/20 | 18:00
Publication of a ProspectusMon 04/05/20 | 17:40
Rights attached to ordinary sharesMon 04/05/20 | 16:18
Total Voting RightsFri 01/05/20 | 15:45
GSK?s Zejula approved in first-line ovarian cancerThu 30/04/20 | 07:00
1st Quarter ResultsWed 29/04/20 | 12:00
Arrangements for Shareholder WebcastWed 29/04/20 | 11:00
Director/PDMR ShareholdingThu 16/04/20 | 15:25
Director/PDMR ShareholdingThu 16/04/20 | 14:21
Director/PDMR ShareholdingThu 16/04/20 | 13:49
Director/PDMR ShareholdingTue 14/04/20 | 16:35
Director/PDMR ShareholdingTue 14/04/20 | 16:31
Director/PDMR ShareholdingTue 14/04/20 | 15:09
Sanofi and GSK collaboration to fight COVID-19Tue 14/04/20 | 12:00
AGM - Change of ArrangementsThu 09/04/20 | 11:52
GSK and Vir Biotechnology enter collaborationMon 06/04/20 | 13:00
GSK completes divestment of HorlicksWed 01/04/20 | 12:57
Total Voting RightsWed 01/04/20 | 11:11
Consumer Healthcare product sales category changesMon 30/03/20 | 16:06
Second Price Monitoring ExtnWed 25/03/20 | 16:42
Price Monitoring ExtensionWed 25/03/20 | 16:37
Second Price Monitoring ExtnTue 24/03/20 | 16:40
Price Monitoring ExtensionTue 24/03/20 | 16:35
Publication of AGM NoticeTue 24/03/20 | 07:00
Directorate ChangeFri 20/03/20 | 14:00
Director/PDMR ShareholdingWed 18/03/20 | 12:20
EMTN Prospectus Supplement UpdateFri 13/03/20 | 17:24
Director/PDMR ShareholdingWed 11/03/20 | 17:00
Director/PDMR ShareholdingMon 09/03/20 | 16:15
Publication of GSK 2019 Form 20-FMon 09/03/20 | 07:00
Annual Financial ReportWed 04/03/20 | 14:53
Total Voting RightsMon 02/03/20 | 11:00
Director/PDMR ShareholdingFri 21/02/20 | 13:00
Director/PDMR ShareholdingThu 20/02/20 | 15:30
Director/PDMR ShareholdingThu 20/02/20 | 14:00
Director/PDMR ShareholdingThu 20/02/20 | 14:00
Director/PDMR ShareholdingWed 19/02/20 | 17:25
Director/PDMR ShareholdingWed 19/02/20 | 16:35
Director/PDMR ShareholdingWed 19/02/20 | 16:28
Director/PDMR ShareholdingWed 19/02/20 | 16:24
Director/PDMR ShareholdingWed 19/02/20 | 16:17
Director/PDMR ShareholdingWed 12/02/20 | 17:05
Director/PDMR ShareholdingTue 11/02/20 | 14:15
Transfer of Treasury SharesTue 11/02/20 | 07:00
Director/PDMR ShareholdingThu 06/02/20 | 16:00
Director/PDMR ShareholdingWed 05/02/20 | 16:15
Final ResultsWed 05/02/20 | 12:00
GSK publishes provisional 2020 Dividend DatesMon 03/02/20 | 15:15
Total Voting RightsMon 03/02/20 | 09:30
Director/PDMR ShareholdingWed 15/01/20 | 07:00
Director/PDMR ShareholdingTue 14/01/20 | 16:46
Director/PDMR ShareholdingTue 14/01/20 | 16:01
Director/PDMR ShareholdingMon 13/01/20 | 18:00
Director/PDMR ShareholdingMon 13/01/20 | 11:41
Director/PDMR ShareholdingMon 13/01/20 | 11:01
Director/PDMR ShareholdingMon 13/01/20 | 10:34
GSK Announces addition to Corporate Executive TeamWed 08/01/20 | 14:37
Total Voting RightsThu 02/01/20 | 09:58
ViiV Healthcare receives complete response letterMon 23/12/19 | 07:01
Director/PDMR ShareholdingWed 18/12/19 | 17:12
Director/PDMR ShareholdingWed 18/12/19 | 16:55
Blocklisting ApplicationTue 17/12/19 | 09:00
Director/PDMR ShareholdingFri 13/12/19 | 16:48
Director/PDMR ShareholdingWed 11/12/19 | 16:57
ViiV submits NDA to FDA for fostemsavirThu 05/12/19 | 12:00
Emma Walmsley - External AppointmentWed 04/12/19 | 17:34
Director/PDMR ShareholdingMon 02/12/19 | 17:52
Total Voting RightsMon 02/12/19 | 16:54
Block listing Interim ReviewTue 26/11/19 | 15:00
Director/PDMR ShareholdingTue 12/11/19 | 15:51
Director/PDMR ShareholdingFri 08/11/19 | 16:22
Director/PDMR ShareholdingWed 06/11/19 | 16:36
Director/PDMR ShareholdingMon 04/11/19 | 17:35
Director/PDMR ShareholdingFri 01/11/19 | 17:19
Total Voting RightsFri 01/11/19 | 09:53
Director/PDMR ShareholdingThu 31/10/19 | 13:34
Director/PDMR ShareholdingWed 30/10/19 | 17:32
Second Price Monitoring ExtnWed 30/10/19 | 12:07
Price Monitoring ExtensionWed 30/10/19 | 12:02
3rd Quarter ResultsWed 30/10/19 | 12:00
GSK divests two travel vaccines to Bavarian NordicMon 21/10/19 | 08:00
Director/PDMR ShareholdingTue 15/10/19 | 17:00
Director/PDMR ShareholdingTue 15/10/19 | 17:00
Director/PDMR ShareholdingTue 15/10/19 | 17:00
Director/PDMR ShareholdingTue 15/10/19 | 17:00
Director/PDMR ShareholdingFri 11/10/19 | 17:34
Director/PDMR ShareholdingFri 11/10/19 | 16:10
Director/PDMR ShareholdingThu 10/10/19 | 16:18
Director/PDMR ShareholdingTue 01/10/19 | 18:18
Total Voting RightsTue 01/10/19 | 13:09
Data show anti-tumour activity with ICOS agonistMon 30/09/19 | 07:00
PRIMA shows Zejula improves PFS in ovarian cancerMon 30/09/19 | 07:00
Director/PDMR ShareholdingThu 26/09/19 | 18:26
Director/PDMR ShareholdingTue 17/09/19 | 17:46
Director/PDMR ShareholdingWed 11/09/19 | 16:30
Director/PDMR ShareholdingWed 04/09/19 | 17:37
Director/PDMR ShareholdingWed 04/09/19 | 12:36
Director/PDMR ShareholdingWed 04/09/19 | 09:33
Total Voting RightsMon 02/09/19 | 11:29
GSK - positive results from pivotal DREAMM-2 studyFri 23/08/19 | 07:00
ViiV results positive for every 2 month injectionThu 22/08/19 | 07:00
GSK submits regulatory file in Japan: DaprodustatWed 21/08/19 | 08:00
Director/PDMR ShareholdingMon 12/08/19 | 15:45
EU approval for Nucala self-administrationThu 01/08/19 | 15:30
Total Voting RightsThu 01/08/19 | 14:10
GSK completes transaction with Pfizer for New JVThu 01/08/19 | 07:00
Director/PDMR ShareholdingTue 30/07/19 | 15:35
ViiV submits cabotegravir to EMA for HIV injectionMon 29/07/19 | 07:00
Director/PDMR ShareholdingWed 24/07/19 | 18:01
ViiV 2DR TANGO switch study positive at 48 weeksWed 24/07/19 | 16:01
ViiV GEMINI studies show high efficacy at 96 weeksWed 24/07/19 | 16:00
Second Price Monitoring ExtnWed 24/07/19 | 12:07
Price Monitoring ExtensionWed 24/07/19 | 12:02
2nd Quarter ResultsWed 24/07/19 | 12:00
Non-Executive ChairmanWed 24/07/19 | 10:00
ViiV presents 96-week data from phase III studyMon 22/07/19 | 17:00
Director/PDMR ShareholdingMon 15/07/19 | 18:19
Director/PDMR ShareholdingMon 15/07/19 | 18:18
Director/PDMR ShareholdingMon 15/07/19 | 18:16
Director/PDMR ShareholdingMon 15/07/19 | 11:42
positive results in Phase 3 PRIMA study of ZEJULAMon 15/07/19 | 07:00
Director/PDMR ShareholdingFri 12/07/19 | 16:35
Director/PDMR ShareholdingFri 12/07/19 | 15:55
Director/PDMR ShareholdingWed 10/07/19 | 15:48
ViiV switch study shows 2DR as effective as 3DRWed 10/07/19 | 07:00
ViiV receives Dovato EU Marketing AuthorisationWed 03/07/19 | 09:00
Total Voting RightsMon 01/07/19 | 12:08
Director/PDMR ShareholdingWed 12/06/19 | 17:10
FDA approval for Nucala self-administrationFri 07/06/19 | 07:00
CHMP positive on GSK's Nucala self-administrationTue 04/06/19 | 08:00
Total Voting RightsMon 03/06/19 | 14:31
Director/PDMR ShareholdingFri 24/05/19 | 10:54
Director/PDMR ShareholdingMon 20/05/19 | 13:44
Block listing Interim ReviewMon 13/05/19 | 17:44
Director/PDMR ShareholdingMon 13/05/19 | 16:19
Result of AGM & GMWed 08/05/19 | 18:23
Trelegy Ellipta asthma study met primary endpointThu 02/05/19 | 17:07
Director/PDMR ShareholdingWed 01/05/19 | 15:11
Total Voting RightsWed 01/05/19 | 14:32
1st Quarter ResultsWed 01/05/19 | 12:00
ViiV submits NDA for HIV monthly 2 drug injectableMon 29/04/19 | 12:00
ViiV receives CHMP Positive Opinion for DovatoFri 26/04/19 | 16:16
Director/PDMR ShareholdingTue 16/04/19 | 17:36
Director/PDMR ShareholdingTue 16/04/19 | 17:35
Director/PDMR ShareholdingTue 16/04/19 | 17:23
Director/PDMR ShareholdingTue 16/04/19 | 17:14
Director/PDMR ShareholdingMon 15/04/19 | 14:45
Director/PDMR ShareholdingFri 12/04/19 | 16:47
Director/PDMR ShareholdingFri 12/04/19 | 16:33
Director/PDMR ShareholdingThu 11/04/19 | 17:01
FDA approves ViiV's two-drug HIV regimen, DovatoTue 09/04/19 | 07:00
Publication of AGM and GM Shareholder DocumentsTue 02/04/19 | 13:00
Total Voting RightsMon 01/04/19 | 16:36
GSK reporting changes - product sales and IFRS 16Thu 28/03/19 | 16:15
Director/PDMR ShareholdingMon 25/03/19 | 17:02
GSK announces further positive data from DREAMM-1Thu 21/03/19 | 16:00
Data from GARNET study evaluating dostarlimabTue 19/03/19 | 17:45
GSK Annual Report 2018 on Form 20-FMon 18/03/19 | 07:00
Director/PDMR ShareholdingTue 12/03/19 | 15:19
Annual Financial ReportTue 12/03/19 | 13:00
Director/PDMR ShareholdingMon 11/03/19 | 18:24
ViiV positive ph3 data for long acting injectableFri 08/03/19 | 07:00
Director/PDMR ShareholdingTue 05/03/19 | 17:20
Total Voting RightsFri 01/03/19 | 10:10
Director/PDMR ShareholdingFri 22/02/19 | 17:30
GSK response to SFO StatementFri 22/02/19 | 11:21
Director/PDMR ShareholdingThu 21/02/19 | 16:37
Director/PDMR ShareholdingThu 21/02/19 | 16:15
Director/PDMR ShareholdingWed 20/02/19 | 14:44
Director/PDMR ShareholdingTue 19/02/19 | 14:26
Director/PDMR Shareholding ReplacementTue 19/02/19 | 13:53
Director/PDMR ShareholdingMon 18/02/19 | 17:13
Director/PDMR ShareholdingMon 18/02/19 | 16:14
Director/PDMR ShareholdingFri 15/02/19 | 18:19
Director/PDMR ShareholdingFri 15/02/19 | 18:16
Director/PDMR ShareholdingFri 15/02/19 | 17:39
Director/PDMR ShareholdingThu 14/02/19 | 10:33
Director/PDMR ShareholdingTue 12/02/19 | 14:05
Director/PDMR ShareholdingTue 12/02/19 | 14:03
Director/PDMR ShareholdingMon 11/02/19 | 12:42
Director/PDMR ShareholdingMon 11/02/19 | 12:40
Director/PDMR ShareholdingMon 11/02/19 | 12:38
Director/PDMR ShareholdingMon 11/02/19 | 12:02
Director/PDMR ShareholdingMon 11/02/19 | 12:01
Director/PDMR ShareholdingFri 08/02/19 | 12:17
Director/PDMR ShareholdingFri 08/02/19 | 12:16
Director/PDMR ShareholdingWed 06/02/19 | 12:20
Final ResultsWed 06/02/19 | 12:01
GSK and Merck announce global alliance for M7824Tue 05/02/19 | 11:58
Total Voting RightsFri 01/02/19 | 15:45
Director/PDMR ShareholdingWed 23/01/19 | 13:10
GSK completes acquisition of TESAROTue 22/01/19 | 13:56
GSK Chairman succession processMon 21/01/19 | 07:00
Director/PDMR ShareholdingTue 15/01/19 | 17:15
Director/PDMR ShareholdingTue 15/01/19 | 16:09
Director/PDMR ShareholdingTue 15/01/19 | 15:01
Director/PDMR ShareholdingTue 15/01/19 | 14:59
Director/PDMR ShareholdingTue 15/01/19 | 14:56
Director/PDMR ShareholdingTue 15/01/19 | 14:47
GlaxoSmithKline Extends Tender Offer for TESAROTue 15/01/19 | 12:00
Director/PDMR ShareholdingFri 11/01/19 | 16:32
Director/PDMR ShareholdingFri 11/01/19 | 16:25
Total Voting RightsWed 02/01/19 | 13:45
Director/PDMR ShareholdingThu 20/12/18 | 17:15
GSK and Pfizer create new Consumer Healthcare JVWed 19/12/18 | 07:00
GSK Commences Tender Offer for TESARO Inc.Fri 14/12/18 | 13:20
Director/PDMR ShareholdingWed 12/12/18 | 16:35
Director/PDMR ShareholdingTue 04/12/18 | 10:07
Total Voting RightsMon 03/12/18 | 14:00
GSK reaches agreement to acquire TESAROMon 03/12/18 | 12:02
GSK to divest Horlicks to UnileverMon 03/12/18 | 08:35
Second Price Monitoring ExtnFri 30/11/18 | 16:40
Price Monitoring ExtensionFri 30/11/18 | 16:35
Director/PDMR ShareholdingThu 29/11/18 | 15:40
GSK - Update on Review of HorlicksThu 29/11/18 | 11:45
Block listing Interim ReviewTue 27/11/18 | 15:25
GSK publishes 2019 Dividend DatesThu 22/11/18 | 13:02
Director/PDMR ShareholdingMon 12/11/18 | 14:45
Blocklisting ApplicationMon 12/11/18 | 09:00
Director DeclarationThu 08/11/18 | 12:43
Director/PDMR ShareholdingFri 02/11/18 | 16:15
Total Voting RightsThu 01/11/18 | 13:40
ViiV positive phIII results with fostemsavirWed 31/10/18 | 14:15
Second Price Monitoring ExtnWed 31/10/18 | 12:07
Price Monitoring ExtensionWed 31/10/18 | 12:02
3rd Quarter ResultsWed 31/10/18 | 12:00
ViiV: positive data for long-acting injectableTue 30/10/18 | 14:30
ViiV - three-year data for long-acting injectableMon 29/10/18 | 10:00
ViiV submits HIV 2DR regulatory application to FDAThu 18/10/18 | 16:00
Director/PDMR ShareholdingThu 18/10/18 | 09:34
Director/PDMR ShareholdingWed 17/10/18 | 17:56
Director/PDMR ShareholdingWed 17/10/18 | 17:50
Director/PDMR ShareholdingWed 17/10/18 | 11:30
Director/PDMR ShareholdingTue 16/10/18 | 16:53
Director/PDMR ShareholdingTue 16/10/18 | 09:30
Director/PDMR ShareholdingTue 16/10/18 | 09:30
Director/PDMR ShareholdingWed 10/10/18 | 15:30
Total Voting RightsMon 01/10/18 | 13:58
Director/PDMR ShareholdingThu 27/09/18 | 16:35
CHMP recommends expansion of Trelegy COPD labelFri 21/09/18 | 12:30
ViiV submits HIV 2DR regulatory application to EMAFri 14/09/18 | 09:00
Director/PDMR ShareholdingWed 12/09/18 | 17:43
New analysis on efficacy of anti-IL5 biologics SEAMon 10/09/18 | 08:00
GSK receives CRL from FDA for mepolizumab in COPDMon 10/09/18 | 07:00
Director/PDMR ShareholdingFri 07/09/18 | 14:24
Director/PDMR ShareholdingFri 07/09/18 | 14:18
Total Voting RightsMon 03/09/18 | 17:00
GSK publishes Q4 2018 Dividend DatesThu 30/08/18 | 17:12
EU approve Nucala in severe asthma in childrenThu 30/08/18 | 08:12
Director/PDMR ShareholdingFri 24/08/18 | 10:16
Positive headline results for ViiV HC ATLAS studyWed 15/08/18 | 07:00
Director/PDMR ShareholdingFri 10/08/18 | 15:00
Director/PDMR ShareholdingWed 08/08/18 | 12:35
Iain Mackay appointed GSK Chief Financial OfficerTue 07/08/18 | 07:00
Publication of Base ProspectusThu 02/08/18 | 17:07
Total Voting RightsThu 02/08/18 | 11:04
Director/PDMR ShareholdingTue 31/07/18 | 17:03
Director/PDMR ShareholdingTue 31/07/18 | 16:37
Director/PDMR ShareholdingFri 27/07/18 | 16:30
CHMP recommend Nucala for severe asthma childrenFri 27/07/18 | 14:47
GSK reports on FDA Ad Com on mepolizumab for COPDThu 26/07/18 | 07:00
Director/PDMR ShareholdingWed 25/07/18 | 16:15
GSK and 23andMe AgreementWed 25/07/18 | 11:00
2nd Quarter ResultsWed 25/07/18 | 11:00
ViiV announces Juluca 100 week data at AIDS 2018Tue 24/07/18 | 09:01
ViiV shows positive phIII data on two-drug comboTue 24/07/18 | 09:00
Director/PDMR ShareholdingThu 19/07/18 | 16:45
Director/PDMR ShareholdingTue 17/07/18 | 17:46
Director/PDMR ShareholdingTue 17/07/18 | 16:54
Director/PDMR ShareholdingTue 17/07/18 | 16:49
Director/PDMR ShareholdingMon 16/07/18 | 14:51
Director/PDMR ShareholdingMon 16/07/18 | 11:11
Director/PDMR ShareholdingFri 13/07/18 | 16:16
Director/PDMR ShareholdingFri 13/07/18 | 16:16
Director/PDMR ShareholdingWed 11/07/18 | 14:42
Total Voting RightsMon 02/07/18 | 14:30
Positive headline results for ViiV GEMINI studiesThu 14/06/18 | 07:00
Director/PDMR ShareholdingTue 12/06/18 | 17:15
GSK announces changes to Corporate Executive TeamTue 12/06/18 | 14:00
GSK completes Consumer Healthcare buyoutFri 01/06/18 | 13:00
Total Voting RightsFri 01/06/18 | 09:42
GSK Once-daily single inhaler triple therapy COPDTue 29/05/18 | 07:00
ViiV granted EU marketing authorisation for JulucaMon 21/05/18 | 11:02
Director/PDMR ShareholdingTue 15/05/18 | 13:39
Director/PDMR ShareholdingFri 11/05/18 | 15:17
Block listing Interim ReviewThu 10/05/18 | 17:20
Director/PDMR Shareholding - replacementWed 09/05/18 | 17:05
Directorate ChangeWed 09/05/18 | 12:00
Result of General MeetingThu 03/05/18 | 18:31
Result of AGMThu 03/05/18 | 18:29
Total Voting RightsTue 01/05/18 | 14:45
Director/PDMR ShareholdingFri 27/04/18 | 12:43
Second Price Monitoring ExtnWed 25/04/18 | 12:07
Price Monitoring ExtensionWed 25/04/18 | 12:02
1st Quarter ResultsWed 25/04/18 | 12:00
Trelegy Ellipta expanded US COPD indicationTue 24/04/18 | 17:41
Director/PDMR ShareholdingFri 20/04/18 | 15:15
Director/PDMR ShareholdingFri 20/04/18 | 15:15
IMPACT study shows benefits of Trelegy ElliptaThu 19/04/18 | 07:00
Landmark IMPACT study to be published in NEJMWed 18/04/18 | 10:34
Director/PDMR ShareholdingTue 17/04/18 | 13:47
Director/PDMR ShareholdingTue 17/04/18 | 13:36
Director/PDMR ShareholdingTue 17/04/18 | 13:30
Director/PDMR ShareholdingTue 17/04/18 | 13:24
Director/PDMR ShareholdingTue 17/04/18 | 13:20
Director/PDMR ShareholdingFri 13/04/18 | 15:50
Director/PDMR ShareholdingFri 13/04/18 | 15:44
Notice of GMFri 13/04/18 | 11:32
Director/PDMR ShareholdingThu 12/04/18 | 15:04
Total Voting RightsTue 03/04/18 | 16:14
Notice of AGMThu 29/03/18 | 13:00
GSK agrees to acquire CH business from NovartisTue 27/03/18 | 07:00
ViiV - CHMP positive opinion for Juluca in EuropeFri 23/03/18 | 11:21
Update regarding Pfizer Inc. Consumer HealthcareFri 23/03/18 | 07:44
Shingrix approved in Europe and JapanFri 23/03/18 | 07:00
GSK 2017 Form 20-FMon 19/03/18 | 07:00
Annual Financial ReportTue 13/03/18 | 14:10
Director/PDMR ShareholdingMon 12/03/18 | 16:30
GSK announces labelling update to Relvar ElliptaThu 08/03/18 | 08:00
ViiV Healthcare announces new dolutegravir dataMon 05/03/18 | 17:01
Nucala OSMO study presented at AAAAI-WAO congressMon 05/03/18 | 14:47
Director/PDMR ShareholdingMon 05/03/18 | 12:04
Director/PDMR ShareholdingFri 02/03/18 | 13:11
Total Voting RightsThu 01/03/18 | 11:16
Director/PDMR ShareholdingThu 22/02/18 | 16:54
Director/PDMR ShareholdingTue 20/02/18 | 13:17
Director/PDMR ShareholdingTue 20/02/18 | 13:16
Director/PDMR ShareholdingTue 20/02/18 | 13:15
Director/PDMR ShareholdingMon 19/02/18 | 18:12
Director/PDMR ShareholdingFri 16/02/18 | 17:29
Director/PDMR ShareholdingFri 16/02/18 | 17:25
Director/PDMR ShareholdingFri 16/02/18 | 11:20
Director/PDMR ShareholdingThu 15/02/18 | 18:09
Director/PDMR ShareholdingThu 15/02/18 | 17:57
Director/PDMR ShareholdingThu 15/02/18 | 17:53
GSK submits landmark IMPACT data - Trelegy ElliptaWed 14/02/18 | 09:00
Director/PDMR ShareholdingTue 13/02/18 | 16:44
Director/PDMR ShareholdingMon 12/02/18 | 14:43
Director/PDMR ShareholdingMon 12/02/18 | 12:47
ViiV Healthcare launches new two-drug HIV studyThu 08/02/18 | 09:31
ViiV files patent infringement litigationThu 08/02/18 | 07:00
Director/PDMR ShareholdingWed 07/02/18 | 13:19
Final ResultsWed 07/02/18 | 12:01
GSK's Bexsero FDA Breakthrough Therapy DesignationWed 07/02/18 | 09:04
Total Voting RightsThu 01/02/18 | 11:52
GSK's Shingrix - positive CHMP opinion in EuropeFri 26/01/18 | 12:30
GSK's Relvar Ellipta - positive CHMP opinionFri 26/01/18 | 09:00
Director/PDMR ShareholdingTue 23/01/18 | 15:22
Director/PDMR ShareholdingFri 19/01/18 | 17:19
Director/PDMR ShareholdingFri 19/01/18 | 17:17
Director/PDMR ShareholdingTue 16/01/18 | 17:48
Director/PDMR ShareholdingMon 15/01/18 | 17:59
Director/PDMR ShareholdingMon 15/01/18 | 17:54
Director/PDMR ShareholdingMon 15/01/18 | 17:34
Director/PDMR ShareholdingMon 15/01/18 | 09:18
Director/PDMR ShareholdingMon 15/01/18 | 09:04
Director/PDMR ShareholdingThu 11/01/18 | 15:33
Director ShareholdingTue 02/01/18 | 14:00
Total Voting RightsTue 02/01/18 | 13:54
FDA approval - on ICS/LABA combinations in asthmaThu 21/12/17 | 09:02
Director/PDMR ShareholdingMon 18/12/17 | 16:21
Transfer of Shares out of TreasuryFri 15/12/17 | 07:00
Director/PDMR ShareholdingTue 12/12/17 | 16:50
GSK gains US approval for Nucala to treat EGPATue 12/12/17 | 16:16
Promising data for GSK2857916 at ASH meetingTue 12/12/17 | 07:00
New data - Shingrix in immune-compromised patientsWed 06/12/17 | 07:00
Director/PDMR ShareholdingFri 01/12/17 | 13:47
Director/PDMR ShareholdingFri 01/12/17 | 13:44
Total Voting RightsFri 01/12/17 | 13:37
ViiV starts Phase 3 HIV prevention study in womenThu 30/11/17 | 07:00
ViiV starts Phase 3 longacting HIV treatment studyMon 27/11/17 | 14:03
GSK submit IMPACT data to support Trelegy ElliptaThu 23/11/17 | 07:00
ViiV Juluca approved in US as first 2-drug regimenWed 22/11/17 | 07:00
GSK publishes 2018 dividend datesTue 21/11/17 | 14:21
Trelegy Ellipta EU approval for treatment of COPDThu 16/11/17 | 07:00
Director/PDMR ShareholdingFri 10/11/17 | 13:15
Block listing Interim ReviewThu 09/11/17 | 17:00
Directorate ChangeWed 08/11/17 | 14:00
Directorate ChangeWed 08/11/17 | 14:00
US regulatory application for mepolizumab in COPDTue 07/11/17 | 15:01
BCMA receives FDA Breakthrough Therapy DesignationThu 02/11/17 | 07:35
Total Voting RightsWed 01/11/17 | 12:01
Superiority of Anoro Ellipta demonstrated for COPDWed 01/11/17 | 11:01
CDC ACIP makes recommendations for use of ShingrixWed 25/10/17 | 17:46
Director/PDMR ShareholdingWed 25/10/17 | 15:21
3rd Quarter ResultsWed 25/10/17 | 12:00
GSK's Shingrix Receives US FDA ApprovalMon 23/10/17 | 07:00
Director/PDMR ShareholdingFri 20/10/17 | 16:12
Director/PDMR ShareholdingFri 20/10/17 | 16:08
Director/PDMR ShareholdingMon 16/10/17 | 16:52
Director/PDMR ShareholdingMon 16/10/17 | 16:42
Director/PDMR ShareholdingMon 16/10/17 | 16:40
Director/PDMR ShareholdingMon 16/10/17 | 16:40
Director/PDMR ShareholdingMon 16/10/17 | 11:02
Director/PDMR ShareholdingMon 16/10/17 | 10:57
GSK first approval of Shingrix in CanadaFri 13/10/17 | 18:31
Director/PDMR ShareholdingFri 13/10/17 | 16:25
Director/PDMR ShareholdingFri 13/10/17 | 16:20
Director/PDMR ShareholdingFri 13/10/17 | 11:53
Director/PDMR ShareholdingWed 11/10/17 | 13:34
Total Voting RightsMon 02/10/17 | 10:19
Director/PDMR ShareholdingMon 25/09/17 | 14:57
Positive IMPACT results for Trelegy in COPDWed 20/09/17 | 07:00
Trelegy Ellipta: FDA approval in COPD receivedTue 19/09/17 | 07:00
Trelegy Ellipta: positive opinion from CHMP EuropeFri 15/09/17 | 07:00
Unanimous FDA approval for Shingrix in over 50sThu 14/09/17 | 07:00
Director/PDMR ShareholdingTue 12/09/17 | 16:07
GSK: phase III results on mepo in COPD in NEJMTue 12/09/17 | 08:57
GSK announce positive results from SLS lung studyMon 11/09/17 | 08:08
Publication of Final TermsFri 08/09/17 | 16:39
Director/PDMR ShareholdingWed 06/09/17 | 16:02
Total Voting RightsFri 01/09/17 | 09:43
Director/PDMR ShareholdingThu 10/08/17 | 16:43
Director/PDMR ShareholdingThu 10/08/17 | 10:50
Base prospectus re £15bn EMTN programmeFri 04/08/17 | 09:06
Total Voting RightsTue 01/08/17 | 11:02
Director/PDMR ShareholdingFri 28/07/17 | 16:03
Director/PDMR ShareholdingFri 28/07/17 | 15:51
Director/PDMR ShareholdingWed 26/07/17 | 13:22
Director/PDMR Shareholding - ReplacementWed 26/07/17 | 12:41
Half-year ReportWed 26/07/17 | 11:00
ViiV announces results from NEAT 022 studyTue 25/07/17 | 13:30
ViiV announces positive results from DAWNINGTue 25/07/17 | 13:30
LATTE-2 phII results presented at IAS in ParisMon 24/07/17 | 09:02
Director/PDMR ShareholdingFri 21/07/17 | 15:34
Director/PDMR ShareholdingFri 21/07/17 | 15:30
GSK submits EU filing for Relvar Ellipta extensionFri 21/07/17 | 13:59
Directorate ChangeFri 21/07/17 | 11:00
Director/PDMR ShareholdingMon 17/07/17 | 18:08
Director/PDMR ShareholdingMon 17/07/17 | 17:44
Director/PDMR ShareholdingMon 17/07/17 | 17:37
Director/PDMR ShareholdingMon 17/07/17 | 17:19
Director/PDMR ShareholdingMon 17/07/17 | 16:53
Director/PDMR ShareholdingMon 17/07/17 | 16:37
Director/PDMR ShareholdingMon 17/07/17 | 14:20
Director/PDMR ShareholdingFri 14/07/17 | 16:58
Director/PDMR ShareholdingFri 14/07/17 | 16:46
Director/PDMR ShareholdingFri 14/07/17 | 16:02
Director/PDMR ShareholdingFri 14/07/17 | 11:57
Director/PDMR ShareholdingWed 12/07/17 | 16:12
Total Voting RightsMon 03/07/17 | 10:05
GSK announces US filing for mepo in EGPAWed 28/06/17 | 16:13
GSK starts phIII study on mepo for nasal polypsTue 27/06/17 | 10:06
Director/PDMR ShareholdingWed 21/06/17 | 14:35
GSK presents Shingrix PhIII study results at ACIPWed 21/06/17 | 14:05
GSK confirms start date for Luke MielsMon 19/06/17 | 16:29